RayBiotech | GenomeWeb

RayBiotech

NEW YORK (GenomeWeb) – RayBiotech today announced a partnership to distribute Scienion's SciFlexarrayer ultra-low volume dispensing systems and related products in China.

NEW YORK (GenomeWeb) – RayBiotech today announced a partnership with XCellCure to develop a cardiovascular disease diagnostic kit.

NEW YORK (GenomeWeb News) – RayBiotech announced on Tuesday a partnership to provide biomarker discovery and validation services to the Fox Chase Cancer Center.

NEW YORK (GenomeWeb News) – In June, Veracyte entered into a loan and security agreement with an unnamed financial institution for term loans of up to $10.0 million in aggregate, the company said in its recent Form 10-Q filed with the US Securities and Exchange Commission.

RayBiotech is applying its protein array technology to internal protein biomarker discovery work.

NEW YORK (GenomeWeb News) – RayBiotech said late Thursday that it has executed a master services agreement with Banner Sun Health Research Institute for the analysis of biomarkers of neurodegenerative disorders.

Thermo Fisher Scientific introduced this week a new data-independent acquisition capability for its Q Exactive mass spectrometer.

NEW YORK (GenomeWeb News) – Presenting at an investors meeting in London this week, Roche said this week that is has more than 200 companion diagnostic projects ongoing across its pharma and diagnostics units.

NEW YORK (GenomeWeb News) – RayBiotech today announced a deal with Norwegian organizations for the use of RayBiotech's antibody arrays for sample analysis services.

Norcross, Ga.-based RayBiotech has launched a partnering program to provide its proteomic analysis services through diagnostic core facilities at academic and government research institutes in the US and Canada.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.